The modulation of colorectal cancer (CRC) by oestrogen receptors has emerged as a field of great promise, drawing attention to the differential roles of receptor subtypes in tumour initiation, ...
A study led by researchers at the Hospital del Mar Research Institute advances one of the most significant milestones in breast cancer treatment, making immunotherapy effective against the most common ...
ER+/PR+ breast cancer is a subtype of ER positive breast cancer where the tumor cells express both estrogen receptors (ER) and progesterone receptors (PR) on the surface. As the most common type of ...
Megestrol, which helps treat hot flashes associated with menopause, may have the added benefit of slowing the growth of ...
How Estrogen Receptor Binds DNA. This illustration shows the estrogen receptor alpha (ERα, in orange) attaching to DNA (in blue) as a pair, or dimer. The image is based on real-time, high-speed atomic ...
A study led by researchers at the Hospital del Mar Research Institute advances one of the most significant milestones in breast cancer treatment, making immunotherapy effective against the most common ...
SurvivorNet on MSN
The evERA Trial: A Promising Treatment Option For Patients With Estrogen Receptor-Positive (ER+), HER2-Negative (HER2-) Breast Cancer
The evERA breast cancer trial marks a turning point for some patients with a specific type of advanced breast cancer known as ...
Chronic kidney disease (CKD) affects more than 10% of the global population and is expected to become the fifth leading cause of death worldwide within the next two decades. Perhaps surprisingly, ...
About three-quarters of breast cancers are ER-positive, meaning the tumours have many oestrogen receptors. These patients receive anti-oestrogen medication, which lowers oestrogen levels but can cause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback